Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Sei Investments Co.

Sei Investments Co. lessened its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 9.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 375,079 shares of the company's stock after selling 40,743 shares during the quarter. Sei Investments Co. owned about 0.17% of Bath & Body Works worth $14,542,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC purchased a new stake in shares of Bath & Body Works in the fourth quarter valued at about $26,000. SRS Capital Advisors Inc. increased its position in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after acquiring an additional 329 shares during the period. True Wealth Design LLC raised its stake in Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after acquiring an additional 1,054 shares during the last quarter. UMB Bank n.a. lifted its position in Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after acquiring an additional 335 shares during the period. Finally, Lindbrook Capital LLC grew its stake in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Stock Up 4.0 %

Shares of BBWI traded up $1.22 during mid-day trading on Wednesday, reaching $31.85. 4,262,829 shares of the company's stock were exchanged, compared to its average volume of 4,522,168. Bath & Body Works, Inc. has a 52-week low of $26.21 and a 52-week high of $52.99. The company has a 50-day simple moving average of $34.84 and a two-hundred day simple moving average of $34.16. The company has a market cap of $6.82 billion, a price-to-earnings ratio of 7.77, a PEG ratio of 0.92 and a beta of 1.89.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.04 by $0.05. The business had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works declared that its board has authorized a stock buyback program on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's management believes its stock is undervalued.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.51%. Bath & Body Works's payout ratio is currently 21.98%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Raymond James restated an "outperform" rating and set a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Robert W. Baird upped their price objective on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a research report on Friday, February 28th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a report on Friday, January 10th. Barclays cut their price target on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a report on Monday, March 3rd. Finally, Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and raised their price objective for the company from $40.00 to $48.00 in a research report on Friday, February 28th. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $45.06.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.